Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Thoracic Oncology"
DOI: 10.1016/j.jtho.2018.04.035
Abstract: Introduction: Skeletal muscle depletion, referred to as sarcopenia, has recently been identified as a risk factor for poor outcomes in various malignancies. However, the prognostic significance of sarcopenia in patients with NSCLC after surgery has… read more here.
Keywords: sarcopenia; sarcopenia resected; postoperative outcomes; effect postoperative ... See more keywords
Adherence to surveillance guidelines in resected NSCLC: Physician compliance and impact on outcomes.
Sign Up to like & getrecommendations! Published in 2017 at "Lung cancer"
DOI: 10.1016/j.lungcan.2017.08.012
Abstract: BACKGROUND Resected NSCLC guidelines have varying recommendations on appropriate post-operative surveillance. There is general consensus that patients require follow-up with clinic visits and/or CT scans every 6 months for the first 2 years. This study… read more here.
Keywords: recurrence; surveillance guidelines; surveillance; impact outcomes ... See more keywords
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC.
Sign Up to like & getrecommendations! Published in 2020 at "Lung cancer"
DOI: 10.1016/j.lungcan.2020.04.006
Abstract: OBJECTIVES Qualitative and quantitative CT imaging features might intercept the multifaceted tumor immune microenvironment (TIME), providing a non-invasive approach to design new prognostic models in NSCLC patients. MATERIALS AND METHODS Our study population consisted of… read more here.
Keywords: surgically resected; radio immune; impact; time ... See more keywords
Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
Sign Up to like & getrecommendations! Published in 2017 at "BMC Cancer"
DOI: 10.1186/s12885-017-3859-3
Abstract: BackgroundThe primary aim of this study was to evaluate the safety of a novel dendritic cell (DC) vaccine pulsed with survivin and MUC1, silenced with suppressor of cytokine signaling 1 (SOCS1), and immune stimulated with… read more here.
Keywords: patients resected; phase; trial; vaccine ... See more keywords
Updated Prognostic Factors in Localized NSCLC
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14061400
Abstract: Simple Summary In resected lung cancer, adjuvant and neoadjuvant chemotherapy following surgery are currently mainly based on TNM classification. With the validation and ongoing trials of targeted therapies in this situation, the relapse risk evaluation… read more here.
Keywords: updated prognostic; lung cancer; prognostic factors; resected nsclc ... See more keywords